Johnson & Johnson COVID vaccine trials are underway in Austin. Benchmark Research is running a clinical trial with 18 participants. They've found the single shot to be 72% effective. CEO Mark Lacey says adding a second dose will bring it closer to 95%. He says they expect at least single doses to be administered by the end of next month.
Photo: Getty Images